Suscribirse

LAPAROSCOPIC RADICAL PROSTATECTOMY: IS IT FEASIBLE AND REASONABLE? - 03/09/11

Doi : 10.1016/S0094-0143(05)70169-5 
Jeffrey A. Cadeddu, MD a, Louis R. Kavoussi, MD b
a Department of Urology, Section of Minimally Invasive Surgery, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas (JAC) 
b The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, Maryland (LRK) 

Resumen

In the United States, prostate cancer is the most frequently diagnosed solid tumor among men.25 Treatment options for tumors clinically confined to the prostate include radical prostatectomy, external beam radiotherapy, brachytherapy, cryotherapy, or expectant management, and each of these therapies is associated with a different morbidity profile. The morbidity for radical prostatectomy includes a hospital stay averaging 2 to 3 days, postoperative pain, prolonged urethral catheterization (>10 days), the risk for incontinence, and the possibility of erectile dysfunction.

To reduce the morbidity of conventional prostatectomy and to improve operative precision, several groups recently have advocated a laparoscopic technique.3, 19 In comparison with a variety of open surgical procedures, laparoscopy has demonstrated a significant advantage in reducing postoperative discomfort, hospital stay, and convalescence7, 13, 23; however, longitudinal evaluation of the oncologic and functional results is imperative before the laparoscopic approach can be offered as an alternative standard of care. For some laparosocpic procedures (i.e., gynecologic oncologic procedures, bladder neck suspension), equivalency in these parameters has not been attained.11, 28

Laparoscopic radical prostatectomy (LRP) must be scrutinized carefully in comparisons. The standard open procedure has a solid track record and well-defined morbidity. Before it can be advocated as a reasonable alternative, LRP must match the contemporary oncologic results and low morbidity of open radical prostatectomy. It must demonstrate adequacy of surgical margins, the absence of significant risk for trocar site implantation, and similar progression-free and disease-specific survival rates.

Purported advantages of laparoscopy in reducing surgical morbidity also need to be compared with open radical prostatectomy in areas such as hospital stay, postoperative discomfort (including catheterization time), blood loss/transfusion requirements, incontinence, impotence, time to convalescence, operative time, and cost. Each of these parameters needs to be evaluated systematically before LRP can be advocated as a reasonable surgical alternative for clinically localized prostate cancer.

El texto completo de este artículo está disponible en PDF.

Esquema


 Address reprint requests to Louis R. Kavoussi, MD, Johns Hopkins Hospital, Department of Endourology, Jefferson Street Building, Suite 161, 600 North Wolfe Street, Baltimore, MD 21287


© 2001  W. B. Saunders Company. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 28 - N° 3

P. 655-661 - août 2001 Regresar al número
Artículo precedente Artículo precedente
  • INTRAOPERATIVE, PERIOPERATIVE, AND LONG-TERM COMPLICATIONS OF RADICAL PROSTATECTOMY
  • Bijan Shekarriz, Jyoti Upadhyay, David P. Wood
| Artículo siguiente Artículo siguiente
  • LAPAROSCOPIC AUGMENTATION CYSTOPLASTY : Surgical Technique
  • Raymond R. Rackley, Joseph B. Abdelmalak

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.